Wada Takahito, Fukushima Yoshimitsu, Saitoh Shinji
Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan.
Am J Med Genet A. 2006 Jul 15;140(14):1519-23. doi: 10.1002/ajmg.a.31310.
X-linked alpha-thalassemia/mental retardation syndrome (ATR-X, OMIM 301040) is a syndromic form of X-linked mental retardation (XLMR). It is caused by a mutation in the ATRX gene, which is also involved in other syndromic forms of XLMR as well as in non-syndromic XLMR, both in males and in females. To analyze the full range of disease-causing mutations for genetic counseling and to establish phenotype-genotype correlations, we have established a new screening method for mutations in the ATRX gene, which uses mismatch-specific endonuclease. We applied this method to confirm 13 known mutations in our patients, some of which have been difficult to be demonstrated by conventional denaturing high-performance liquid chromatography. Furthermore, we found four additional mutations in four ATR-X patients whose clinical diagnosis had not been confirmed at the molecular level. In this method, experimental conditions do not need to be altered depending on mutation sites, and it should be the alternative method for mutation screening.
X连锁α地中海贫血/智力发育迟缓综合征(ATR-X,OMIM 301040)是一种X连锁智力发育迟缓(XLMR)的综合征形式。它由ATRX基因突变引起,该基因在其他XLMR综合征形式以及男性和女性的非综合征性XLMR中也有涉及。为了分析用于遗传咨询的致病突变的全谱并建立表型-基因型相关性,我们建立了一种新的ATRX基因突变筛查方法,该方法使用错配特异性内切酶。我们应用此方法在我们的患者中确认了13个已知突变,其中一些突变难以通过传统的变性高效液相色谱法证实。此外,我们在4例临床诊断尚未在分子水平得到证实的ATR-X患者中又发现了4个突变。在该方法中,实验条件无需根据突变位点进行改变,它应该是突变筛查的替代方法。